Asked by: Steve Yemm (Labour - Mansfield)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that patients with chronic obstructive pulmonary disease receive community-based care with specialist input; and what assessment he has made of the effectiveness of that approach.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
NHS England is investing £3.61 million of funding to expand an approach that allows more people with chronic obstructive pulmonary disease (COPD) at rising risk of admission to be proactively identified and supported during winter 2025/26. A nationally coordinated evaluation is planned to take place, providing a consistent evidence base, sharing learning, and informing future investment in interventions to reduce COPD emergency admissions.
As part of the implementation of the 10-Year Health Plan, we are expanding neighbourhood teams and exploring how new roles such as the community health worker model can be tailored to support Core20PLUS5 populations including those with COPD.
Asked by: Steve Yemm (Labour - Mansfield)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of trends in the number of patients with metabolic dysfunction–associated steatohepatitis on the NHS in (a) Nottinghamshire and (b) Mansfield constituency; and what steps he is taking to tackle metabolic dysfunction.
Answered by Ashley Dalton
Data on hospital admission rates for metabolic dysfunction-associated steatotic liver disease (MASLD), of which metabolic dysfunction–associated steatohepatitis is a stage in some cases, is available at the Department’s Fingertips website, and can be used by regional commissioners to monitor the incidence of the disease. This data is available at county, but not constituency level. Further information is available at the following link:
Recognising the increasing burden that liver disease has on the population, NHS England has initiated a liver transformation programme. This focusses on awareness, prevention, diagnosis, detection and treatment of all forms of liver disease. The liver transformation programme has developed a data pack for regional commissioners using the Fingertips data mentioned above, to raise awareness of incidence of liver disease. It is for commissioners in integrated care boards to determine how best to use this information as part of local commissioning decisions.
The Government is taking decisive action to tackle ill health and shift the focus on diseases such as MASLD from treatment to prevention. As part of our 10-Year Health Plan, we are improving diets, reducing physical inactivity, and creating healthier environments so that fewer people reach the point of needing treatment. This includes updating the standards behind the advertising and promotions restrictions on ‘less healthy’ food and drink and requiring all large food businesses to report against standardised metrics on the healthiness of food sales. We will also get millions moving more through our national movement campaign and We are committed to taking crucial steps to help people make healthier choices about alcohol, including making it a legal requirement for alcohol labels to display health warnings and consistent nutritional information.
Asked by: Steve Yemm (Labour - Mansfield)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, when he expects treatments for fatty liver disease to be approved for use on the NHS; what assessment he has made of the readiness of the NHS to make such treatments available; and what steps he is taking to ensure eligible patients will receive these treatments once approved.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
Newly licensed medicines are appraised by the National Institute for Health and Care Excellence (NICE), which is the independent body responsible for developing evidence-based guidance for the National Health Service on whether new medicines represent a clinically and cost-effective use of resources. NICE aims wherever possible to issue draft guidance on new medicines close to the time of licensing. The NHS in England is legally required to fund drugs recommended by NICE, usually within three months of final guidance.
NICE is currently evaluating potential new treatments for metabolic dysfunction-associated steatohepatitis (MASH) in anticipation of the medicines being granted a marketing authorisation by the Medicines and Healthcare Products Regulatory Agency (MHRA) with guidance expected later this year. NHS England is actively preparing to support the potential introduction of new treatments for MASH, including fatty liver disease with fibrosis, alongside the ongoing NICE appraisal process.
The Department and NHS England will continue to work to ensure that, once approved, effective new treatments for fatty liver disease are introduced in a way that is fair, affordable and protects the wider NHS, while ensuring that patients with the greatest clinical need are able to benefit as quickly as possible.
Asked by: Steve Yemm (Labour - Mansfield)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if he will meet with young people with cancer supported by Teenage Cancer Trust ahead of the publication of the National Cancer Plan.
Answered by Ashley Dalton
The Department is committed to ensuring the unique needs of young people with cancer are carefully considered as part of the National Cancer Plan, due for publication in the coming weeks. Since its launch on 4 February 2025, the Children and Young People (CYP) Cancer Taskforce has been working to identify tangible ways to improve outcomes and experiences for children and young people with cancer. The taskforce will explore opportunities for improvement across detection and diagnosis, genomic testing and treatment, research and innovation, and patient experience.
The Government is committed to including the voices of young cancer patients in the work of the taskforce and the National Cancer Plan. That’s why the Government assembled a Patient Experience Panel, made up of young people with lived experience of cancer and their families, which will feed directly into the work of the taskforce.
The Government is also aware of the unique challenges that teenagers with cancer face, often falling in between paediatric and adult care. The CYP Cancer Taskforce has a dedicated charity sub-group which has engaged with the Teenage Cancer Trust, alongside other charitable groups, to ensure these challenges are addressed in the National Cancer Plan. I would like to thank the Teenage Cancer Trust, other charities, and the CYP Cancer Taskforce for their valuable input into the plan.
Asked by: Steve Yemm (Labour - Mansfield)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what policies his Department plans to include in the National Cancer Plan on increasing access to clinical trials for (a) teenagers and (b) young adults with cancer.
Answered by Ashley Dalton
The Department is committed to getting the National Health Service diagnosing cancer earlier and treating it faster, so that more people survive, and we will improve the experience of cancer patients across the system, including teenagers and young adults.
Since the launch of the Children and Young People Cancer Taskforce on 4 February 2025, the taskforce has been exploring opportunities for clinical and non-clinical improvement across a range of areas. These include data, early detection and diagnosis, patient experience, genomic testing and treatment, and research and innovation, which includes access to clinical trials. The Government is aware of the unique challenges that teenagers and young adults with cancer face, often falling in between paediatric and adult care, and the work of the taskforce has included a specific focus on this issue.
As part of its work, the taskforce will ensure that the needs of teenagers and young adults are carefully considered as part of the forthcoming National Cancer Plan. The plan will have patients at its heart and will cover the entirety of the cancer pathway, from referral and diagnosis to treatment and ongoing care, as well as research and innovation. It will seek to improve every aspect of cancer care to better the experience and outcomes for people with cancer. Our goal is to reduce the number of lives lost to cancer over the next ten years, for all patient groups. This will include teenagers and young adults with cancer.
Asked by: Steve Yemm (Labour - Mansfield)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what policies his Department plans to include in the National Cancer Plan on the earlier diagnosis of (a) teenagers and (b) young adults with cancer.
Answered by Ashley Dalton
The Department is committed to getting the National Health Service diagnosing cancer earlier and treating it faster, so that more people survive, and we will improve the experience of cancer patients across the system, including teenagers and young adults.
Since the launch of the Children and Young People Cancer Taskforce on 4 February 2025, the taskforce has been exploring opportunities for clinical and non-clinical improvement across a range of areas. These include data, early detection and diagnosis, patient experience, genomic testing and treatment, and research and innovation, which includes access to clinical trials. The Government is aware of the unique challenges that teenagers and young adults with cancer face, often falling in between paediatric and adult care, and the work of the taskforce has included a specific focus on this issue.
As part of its work, the taskforce will ensure that the needs of teenagers and young adults are carefully considered as part of the forthcoming National Cancer Plan. The plan will have patients at its heart and will cover the entirety of the cancer pathway, from referral and diagnosis to treatment and ongoing care, as well as research and innovation. It will seek to improve every aspect of cancer care to better the experience and outcomes for people with cancer. Our goal is to reduce the number of lives lost to cancer over the next ten years, for all patient groups. This will include teenagers and young adults with cancer.
Asked by: Steve Yemm (Labour - Mansfield)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if he will take steps to help improve data collection on (a) teenagers and (b) young adults with cancer in relation to (i) staging at diagnosis, (ii) routes to diagnosis, (iii) emergency presentation, (iv) waiting times and (v) access to clinical trials.
Answered by Ashley Dalton
The Department is committed to getting the National Health Service diagnosing cancer earlier and treating it faster, so that more people survive, and we will improve the experience of cancer patients across the system, including teenagers and young adults.
Since the launch of the Children and Young People Cancer Taskforce on 4 February 2025, the taskforce has been exploring opportunities for clinical and non-clinical improvement across a range of areas. These include data, early detection and diagnosis, patient experience, genomic testing and treatment, and research and innovation, which includes access to clinical trials. The Government is aware of the unique challenges that teenagers and young adults with cancer face, often falling in between paediatric and adult care, and the work of the taskforce has included a specific focus on this issue.
As part of its work, the taskforce will ensure that the needs of teenagers and young adults are carefully considered as part of the forthcoming National Cancer Plan. The plan will have patients at its heart and will cover the entirety of the cancer pathway, from referral and diagnosis to treatment and ongoing care, as well as research and innovation. It will seek to improve every aspect of cancer care to better the experience and outcomes for people with cancer. Our goal is to reduce the number of lives lost to cancer over the next ten years, for all patient groups. This will include teenagers and young adults with cancer.
Asked by: Steve Yemm (Labour - Mansfield)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department plans to take to ensure that the National Cancer Plan for England provides age-appropriate information on the symptoms of cancer for young people.
Answered by Ashley Dalton
The Department is committed to getting the National Health Service diagnosing cancer earlier and treating it faster, so that more people survive, and we will improve the experience of cancer patients across the system, including teenagers and young adults.
Since the launch of the Children and Young People Cancer Taskforce on 4 February 2025, the taskforce has been exploring opportunities for clinical and non-clinical improvement across a range of areas. These include data, early detection and diagnosis, patient experience, genomic testing and treatment, and research and innovation, which includes access to clinical trials. The Government is aware of the unique challenges that teenagers and young adults with cancer face, often falling in between paediatric and adult care, and the work of the taskforce has included a specific focus on this issue.
As part of its work, the taskforce will ensure that the needs of teenagers and young adults are carefully considered as part of the forthcoming National Cancer Plan. The plan will have patients at its heart and will cover the entirety of the cancer pathway, from referral and diagnosis to treatment and ongoing care, as well as research and innovation. It will seek to improve every aspect of cancer care to better the experience and outcomes for people with cancer. Our goal is to reduce the number of lives lost to cancer over the next ten years, for all patient groups. This will include teenagers and young adults with cancer.
Asked by: Steve Yemm (Labour - Mansfield)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to (a) improve early diagnosis, (b) increase funding for research and (c) improve access to specialist (i) support and (ii) treatment for patients with scleroderma.
Answered by Ashley Dalton
The Government is committed to improving the lives of those living with rare diseases, such as scleroderma. The UK Rare Diseases Framework sets out four priorities collaboratively developed with the rare disease community. These include helping patients get a final diagnosis faster; increasing awareness of rare diseases among healthcare professionals; better coordination of care; and improving access to specialist care, treatments, and drugs. We published the annual England Rare Diseases Action Plan in February 2025, where we report on the steps we have taken to advance these priorities.
Pioneering research is an underpinning theme of the Framework. The Department for Health and Social Care funds and supports research into rare diseases such as scleroderma through the National Institute for Health and Care Research (NIHR). The NIHR welcomes funding applications for research into any aspect of human health, including rare diseases. The usual practice of the NIHR and other research funders is not to ring-fence funds for expenditure on particular topics.
The 2025 England Rare Disease Action Plan includes information on research for rare diseases through significant investments to support rare disease research. This includes the Rare Disease Research UK Platform, a £14 million investment over five years from the Medical Research Council (MRC) and NIHR, announced in 2023, which is now established and positioned well within the rare disease research landscape. In December 2024, the MRC launched the first two MRC Centres of Research Excellence, both studying gene therapies, and each worth up to £50 million over 14 years.
Asked by: Steve Yemm (Labour - Mansfield)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he plans to take through the (a) NHS 10 Year Plan and (b) National Cancer Plan to increase levels of participation in NHS cancer screening programmes for (i) cervical, (ii) bowel, and (iii) breast cancer.
Answered by Ashley Dalton
The National Health Service continues to prioritise improving cancer screening uptake. Early diagnosis is a key focus of the National Cancer Plan, which will build on the three shifts in care set out in the 10-Year Health Plan, including from sickness to prevention, to diagnose cancers earlier. Through the 10-Year Health Plan, the NHS will reach patients earlier, to catch illness before it spreads, and to prevent it in the first place.
Furthermore, in March 2025, NHS England published its Cervical cancer elimination plan by 2040 – plan for England, setting out how the NHS will improve equitable uptake and coverage across cervical screening to meet the goal to eliminate cervical cancer by 2040. Further information on the Cervical cancer elimination plan by 2040 – plan for England is available at the following link:
https://www.england.nhs.uk/publication/cervical-cancer-elimination-by-2040-plan-for-england/
From January 2026, screening providers in the NHS Cervical Screening Programme in England will be able to offer human papillomavirus self-sampling kits to women if they have not attended their appointment for six months or more following routine invitation.
The NHS is also planning to publish a Breast Screening Programme Uptake Improvement Plan to help improve uptake and address inequalities. NHS England also launched the first ever national NHS Breast screening campaign to widespread media attention. It ran across television, radio, social media, and outdoor advertising during February and March 2025, targeting women of breast screening age, with a focus on those least likely to attend, including younger women, those in deprived areas, ethnic minorities, and disabled women.
The bowel cancer screening standards have recently been reviewed, with changes taking effect from 1 April 2025. This will update the achievable and acceptable thresholds for both uptake and coverage. To further increase coverage, NHS England is delivering new approaches to communicating with people about screening through the NHS App and improving the way eligible people are identified and invited for screening through the transformation of screening programme digital services.